Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Sep;86(18):7179-82.
doi: 10.1073/pnas.86.18.7179.

Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin

Affiliations

Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin

W A Dittman et al. Proc Natl Acad Sci U S A. 1989 Sep.

Abstract

We have measured mRNA levels for thrombomodulin, an endothelial membrane cofactor for the activation of protein C by thrombin, in a mouse hemangioma cell line. Cycloheximide, an inhibitor of protein synthesis, increased levels of thrombomodulin mRNA, as measured in an S1 nuclease protection assay, to 2.5-4.0 times control levels. Thrombomodulin transcription in response to cycloheximide treatment, as determined by nuclear run-on analysis, was 3.9 +/- 1.3 (mean +/- SD) times that found in untreated cells. Thrombin also increased thrombomodulin mRNA levels to 151 +/- 21% (mean +/- SD) of control levels after 2 hr. Transcription increased in response to thrombin by 2.1- to 7.3-fold. The combination of thrombin and cycloheximide had no additive effect on thrombomodulin mRNA levels. Thrombin treatment of hemangioma cells also caused an increase in thrombomodulin protein synthesis to 142 +/- 17% (mean +/- SD) of control levels as determined by immunoprecipitation of [32S]methionine-labeled thrombomodulin. We conclude that thrombomodulin expression is determined in part by the rate of transcription and that thrombomodulin mRNA levels in hemangioma cells are increased by treatment with cycloheximide or thrombin. The increased transcription in response to cycloheximide suggests the existence of a labile protein repressor of thrombomodulin transcription.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Blood. 1989 Jan;73(1):159-65 - PubMed
    1. Nature. 1988 Nov 24;336(6197):396-9 - PubMed
    1. Nucleic Acids Res. 1989 Jan 25;17(2):802 - PubMed
    1. Blood. 1989 Feb 15;73(3):639-42 - PubMed
    1. Mol Cell Biol. 1989 Jan;9(1):92-9 - PubMed

Publication types